DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts
Authors:
- Florian ReinhardtFRFlorian Reinhardt
- Luisa CoenLCLuisa Coen
- Mahdi RivandiMRMahdi Rivandi
- André FrankenAFAndré Franken
- Eunike Sawitning Ayu SetyonoESEunike Sawitning Ayu Setyono
- Tobias LindenbergTLTobias Lindenberg
- Jens EberhardtJEJens Eberhardt
- Tanja FehmTFTanja Fehm
- Dieter NiederacherDNDieter Niederacher
- Franziska KnopfFKFranziska Knopf
- Hans NeubauerHNHans Neubauer
Open Access
Abstract
Circulating tumor cells (CTCs) serve as crucial metastatic precursor cells, but their study in animal models has been hindered by their low numbers. To address this challenge, we present DanioCTC, an innovative xenograft workflow that overcomes the scarcity of patient-derived CTCs in animal models. By combining diagnostic leukapheresis (DLA), the Parsortix microfluidic system, flow cytometry, and the CellCelector setup, DanioCTC effectively enriches and isolates CTCs from metastatic breast cancer (MBC) patients for injection into zebrafish embryos. Validation experiments confirmed that MDA-MB-231 cells, transplanted following the standard protocol, localized frequently in the head and blood-forming regions of the zebrafish host. Notably, when MDA-MB-231 cells spiked (i.e., supplemented) into DLA aliquots were processed using DanioCTC, the cell dissemination patterns remained consistent. Successful xenografting of CTCs from a MBC patient revealed their primary localization in the head and trunk regions of zebrafish embryos. DanioCTC represents a major step forward in the endeavors to study the dissemination of individual and rare patient-derived CTCs, thereby enhancing our understanding of metastatic breast cancer biology and facilitating the development of targeted interventions in MBC. Summary statement: DanioCTC is a novel workflow to inject patient-derived CTCs into zebrafish, enabling studies of the capacity of these rare tumor cells to induce metastases.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (387653785, KN 1102/2-1, HO 1875/26-1, 70112504, 70114705)
- Deutsche Forschungsgemeinschaft (387653785, KN 1102/2-1, HO 1875/26-1, 70112504, 70114705)
- Deutsche Krebshilfe (387653785, KN 1102/2-1, HO 1875/26-1, 70112504, 70114705)
This publication has 38 references indexed in Scilit:
- Zebrafish cancer: the state of the art and the path forwardNature Reviews Cancer, 2013
- Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell LinesPLOS ONE, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Circulating tumour cells in cancer patients: challenges and perspectivesTrends in Molecular Medicine, 2010
- AACR Centennial Series: The Biology of Cancer Metastasis: Historical PerspectiveCancer Research, 2010
- Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeletonDevelopment, 2008
- Genetic and cellular analyses of zebrafish atrioventricular cushion and valve developmentDevelopment, 2005
- Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant DiseasesClinical Cancer Research, 2004
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- A Bone-Seeking Clone Exhibits Different Biological Properties from the MDA-MB-231 Parental Human Breast Cancer Cells and a Brain-Seeking Clone In Vivo and In VitroJournal of Bone and Mineral Research, 2001